Accord Logo

Intended for UK patients and members of the public

Additional Information

Please note that some products on this page share the same name. Please take extra care to make sure the PL number of your medicine matches the PL number of the medicine you select on this page. The PL number can be found on your medicine bottle or carton. If you are unsure, please contact your pharmacist.

Midazolam Solution

Active Ingredients

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Midazolam 1 mg/ml solution for injection/infusion in pre filled syringe

PL Number:
0142/1263
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Midazolam 1mg/ml solution for injection or infusion

PL Number:
20075/0080
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Active

Product Documentation

  • To update SmPC sections 4.2, 4.4, 4.5, 5.1 and leaflet sections 2, 3, 4 in line with the reference product (Hypnovel 10 mg/2 ml Solution for Injection; MA number: PA2239/007/001; MAH: Cheplapharm Arzneimittel GmbH, Germany).

    Additionally, editorial updates have been made to the PIL.

  • - update European Pharmacopoeial Certificate of Suitability from already approved manufacturer i.e. RA Chem Pharma Limited; CEP update from R1-CEP 2010-141-Rev 00 to R1-CEP 2010-141-Rev 01.

    - update European Pharmacopoeial Certificate of Suitability from already approved manufacturer i.e. RA Chem Pharma Limited; CEP update from R1-CEP 2010-141-Rev 01 to R1-CEP 2010-141-Rev 02.

    - update European Pharmacopoeial Certificate of Suitability from already approved manufacturer i.e. Sun Pharmaceuticals Industries Limited; CEP update from R1-CEP 2002-059-Rev 03 to R1-CEP 2002-059-Rev 04.

    - update European Pharmacopoeial Certificate of Suitability from already approved manufacturer i.e. Sun Pharmaceuticals Industries Limited; CEP update from R1-CEP2002-059-Rev 04 to R1-CEP 2002-059-Rev 05.

     

    A.7. Deletion batch release site Accord Healthcare B.V., Netherlands

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Discontinued Other versions of this medicine may still be available. Information for reference purposes.

Midazolam 2 mg/ml solution for injection or infusion

PL Number:
20075/0337
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Discontinued

Product Documentation

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Midazolam 5 mg/ml solution for injection or infusion

PL Number:
20075/0338
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Active

Product Documentation

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Midazolam 5mg/ml solution for injection or infusion

PL Number:
20075/0081
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Active

Product Documentation

  • To update SmPC sections 4.2, 4.4, 4.5, 5.1 and leaflet sections 2, 3, 4 in line with the reference product (Hypnovel 10 mg/2 ml Solution for Injection; MA number: PA2239/007/001; MAH: Cheplapharm Arzneimittel GmbH, Germany).

    Additionally, editorial updates have been made to the PIL.

  • - update European Pharmacopoeial Certificate of Suitability from already approved manufacturer i.e. RA Chem Pharma Limited; CEP update from R1-CEP 2010-141-Rev 00 to R1-CEP 2010-141-Rev 01.

    - update European Pharmacopoeial Certificate of Suitability from already approved manufacturer i.e. RA Chem Pharma Limited; CEP update from R1-CEP 2010-141-Rev 01 to R1-CEP 2010-141-Rev 02.

    - update European Pharmacopoeial Certificate of Suitability from already approved manufacturer i.e. Sun Pharmaceuticals Industries Limited; CEP update from R1-CEP 2002-059-Rev 03 to R1-CEP 2002-059-Rev 04.

    - update European Pharmacopoeial Certificate of Suitability from already approved manufacturer i.e. Sun Pharmaceuticals Industries Limited; CEP update from R1-CEP2002-059-Rev 04 to R1-CEP 2002-059-Rev 05.

     

    A.7. Deletion batch release site Accord Healthcare B.V., Netherlands

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

General FAQs

For any further assistance, please get in touch.

View product information as a: